 |
Email the Society |
 |
Donations |
ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
Mailing address:
GPO Box 383,
Adelaide,
South Australia 5001
Office:
266 Port Road,
Hindmarsh,
South Australia 5007
Ph: (08) 8346 3237
('834 MECFS')
Office Hours:
Wednesdays, 10am-3pm
Support Line:
(Mondays and Thursdays,
10am-3pm)
Ph: (08) 8346 3237
SA country callers:
Ph: 1300 128 339
(local call)
FIBROMYALGIA HELP: Contact Fibromyalgia SA at the Arthritis Foundation of SA 118 Richmond Road, Marleston 5033 Ph: (08) 8379 5711 |
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
|
Disclaimer
ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
| Become a Member | |||
|
Flu vaccines
Thursday 30 August 2007
Some members have contacted us regarding influenza vaccines, given the current number and severity of flu cases in Adelaide.
Some members have not yet had a vaccination this year and are wondering whether they should. There is no one right answer to this question.
Dr Peter Del Fante, medical adviser to ME/CFS Society SA, advises that Fluvax is not a live vaccine, and as such is generally tolerated well by most of his CFS patients, but can cause a relapse in some. He adds that another factor to bear in mind is that this year’s flu season bugs are more potent than ususal. On the other hand, bear in mind that technically what is regarded as the traditional flu season will end sometime in October.
Hence it is a case for each person with their GP and/or specialist to weigh up the benefits provided by vaccination against the possible risks, given the patient’s medical history.
Previous Page |
